Journals / Journal of the Turkish-German Gynecological Association / 2011 / Cilt: 12 - Sayı: 1

Endometrium kanserinde hücre tipinin cerrahi-patolojik risk faktörlerine etkisi

The effect of cell type on surgico-pathologic risk factors in endometrial cancer

Pages
9–14
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that the presence and type (stromal/glandular) of cervical invasion, depth of myometrial invasion and presence of lymphovascular space invasion were not affected by cell type.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study the effect of histologic subtype as a surgicopathologic risk factor in endometrial cancer is evaluated.
📊
Key Findings & Data:Material and Methods: We evaluated 182 patients who underwent systematic lymphadenectomy up to the level of the renal vessels and at least 15 lymph nodes were dissected from the pelvic area and 10 lymph nodes from the para-aortic area. investigation of whether endometrioid and aggressive cell types (serous papillary cell and clear cell) affect the distribution of surgicopathologic risk factors among endometrial cancer cases was carried out.
💡
Conclusion & Impact:It was found that the presence and type (stromal/glandular) of cervical invasion, depth of myometrial invasion and presence of lymphovascular space invasion were not affected by cell type.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this study the effect of histologic subtype as a surgicopathologic risk factor in endometrial cancer is evaluated. Material and Methods: We evaluated 182 patients who underwent systematic lymphadenectomy up to the level of the renal vessels and at least 15 lymph nodes were dissected from the pelvic area and 10 lymph nodes from the para-aortic area. investigation of whether endometrioid and aggressive cell types (serous papillary cell and clear cell) affect the distribution of surgicopathologic risk factors among endometrial cancer cases was carried out. Results: Patients in the aggressive cell type group were older and the tumor size was significantly smaller. There was no difference between the two groups for the total number of dissected lymph nodes except for the external iliac area. Although the difference is not statistically significant, the total number of lymph nodes dissected in the aggressive group was less (54.3 vs 62.9, p=0.067) than that of the endometrioid cell type group. While the incidence of pelvic lymph node metastasis in the aggressive group was 59.1% the incidence was 15.6% in the endometrioid cell type group (p>0.001). The possibility of lymph node metastasis for aggressive cell type endometrial carcinoma in the para-aortic area was twice the endometrioid cell type group. It was found that the presence and type (stromal/glandular) of cervical invasion, depth of myometrial invasion and presence of lymphovascular space invasion were not affected by cell type. Conclusion: Aggressive cell types significantly increase the adnexial and lymph node metastasis in endometrial cancer.

Özet

Amaç: Bu çalışmada endometrium kanserinde hücre tipinin cerrahi-patolojik risk faktörleri üzerine olan etkisi araştırıldı. Gereç ve Yöntemler: Endometrium kanseri nedeniyle renal damarlar seviyesine kadar sistematik lenf nodu diseksiyonu yapılan 182 hasta retrospektif olarak değerlendirildi. Lenf nodu diseksiyonu yapılan olgularda pelvik bölgeden en az 15 adet, para-aortic bölgeden de en az 10 adet lenf nodu çıkarılmıştır. Hastalar yapılan histolojik değerlendirme sonucuna göre hücre tipine göre endometrioid hücre tipi ve agresif hücre tipi (seröz papiller ve berrak hücreli) olmak üzere 2 gruba ayrıldı.Bu iki grup cerrahi-patolojik risk faktörlerinin dağılımı açısından karşılaştırıldı. Bulgular: Agresif hücre tipi grubunda yer alan hastaların yaş ortalaması daha yüksekti ve tümör boyutu daha küçüktü. İki grup arasında eksternal iliak bölge dışında diseke edilen lenf nodu sayısı açısından fark olmadığı bulundu. Agresif hücre tipi grubunda çıkarılan toplam lenf nodu sayısı endometrioid hücre tipi grubundan daha azdı fakat fark istatistiksel olarak anlamlı değildi (54.3 vs 62.9, p=0.067). Agresif hücre tipi grubunda pelvik lenf nodu metastazı insidansı %59.1 iken endometrioid hücre tipi grubunda insidans %15.6 olarak bulundu (p>0.001). agresif hücre tipi grubunda para-aortic lenf nodu metastazı olasılığının diğer grubun 2 katı olduğu görüldü. Servikal invazyon ve invazyonun tipinin (stromal/glandüler), miyometrial invazyonun derinliğinin ve lenfovasküler alan invazyonunun hücre tipinden etkilenmediği görüldü. Sonuç: Endometrium kanserinde agresif hücre tipi adneksiyal alan ve lenf nodu metastazını istatistiksel olarak anlamlı ölçüde arttırmaktadır.

🔖

Cite This Article

BORAN, N., KÖSE, M. F., TURAN, A. T., GÜNDOĞDU, B., TULUNAY, G., ÖZGÜL, N., ÖZFUTTU, A., BOZTOSUN, A., DÜNDAR, B. (2022). Endometrium kanserinde hücre tipinin cerrahi-patolojik risk faktörlerine etkisi. Journal of the Turkish-German Gynecological Association, Cilt: 12 - Sayı: 1, 9–14. https://ajindex.com/articles/567745

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Can- cer J Clin 1999
  2. [CrossRef] 2. Tropé C, Kristensen GB, Abeler VM. Best Pract Res Clin Obstet Gynaecol. 2001
  3. Clear-cell and papillary serous cancer: treatment options. [CrossRef] 3. Abeler VM, Vergote IB, Kjorstad KE, Tropé CG. Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern. Cancer 1996
  4. [CrossRef] 4. Christopherson WM, Alberhasky RC, Connelly PJ. Carcinoma of the endometrium: I. A clinicopathologic study of clear-cell carcinoma and secretory carcinoma. Cancer 1982
  5. [CrossRef] 5. Sherman ME, Bitterman P, Rosenshein NB, Delgado G, Kurman RJ. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. American Journal of Sur- gical Pathology 1992
  6. [CrossRef] 6. Abeler VM, Kjorstad KE. Serous papillary carcinoma of the endo- metrium: a histopathological study of 22 cases. Gynecologic Oncol- ogy 1990
  7. [CrossRef] 7. Goff BA, Kato D, Schmidt RA, Ek M, Ferry JA, Muntz HG et al Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol 1994
  8. [CrossRef] 8. Carcangui M, Chambers J. Uterine papillary serous carcinoma: a study of 108 cases with emphasis on the prognostic significance of associ- ated endometrial carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol 1992
  9. [CrossRef] 9. Carcangiu M, Chambers J. Early pathologic stage clear cell carci- noma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathological features and survival. Int J Gyn Pathol 1995
  10. [CrossRef] 10. Potish RA, Twiggs LB, Adcock LL, Prem KA. Role of whole abdomi- nal radiation therapy in the management of endometrial cancer: Prognostic importance of factors indicating peritoneal metastases. Gynecol Oncol 1985
  11. [CrossRef] 11. Gibbons S, Martinez A, Schray M. Adjuvant whole abdominopelvic irradiation for high-risk endometrial carcinoma. Int J Radiat Oncol Biol Phys 1991
  12. [CrossRef] 12. Burke TW, Gershenson DM. Chemotherapy as adjuvant and salvage treatment in women with endometrial carcinoma. Clin Obstet Gy- necol 1996
  13. [CrossRef] 13. Pustilnik T, Burke TW. Adjuvant chemotherapy for high-risk endo- metrial cancer. Semin Radiat Oncol 2000
  14. [CrossRef] 14. Craighead PS, Sait K, Stuart GC, Arthur K, Nation J, Duggan M et al. Managemen